stars 1 stars 2 stars 3

EDAP TMS is a recognized leader in robotic energy-based therapies. EDAP TMS develops, manufactures, promotes and distributes minimally invasive devices for various conditions using ultrasound technology. By combining the latest advancements in imaging, robotics, and the precise, non-invasive delivery of energy, EDAP TMS introduced the Focal One® in Europe and the United States as the leading focal therapy tool for the prostate, with the potential to expand to multiple indications beyond prostate cancer. EDAP TMS is listed on NASDAQ market in New York under ticker symbol “EDAP”.

EDAP TMS Questions

The EDAP TMS annual revenue was $49.3 million in 2026.

Frédéric Pech is the Directeur Des Opérations of EDAP TMS.

11 people are employed at EDAP TMS.

EDAP TMS is based in Vaulx-en-Velin, Auvergne-Rhône-Alpes.

The NAICS codes for EDAP TMS are [55, 33, 423, 42].

The SIC codes for EDAP TMS are [382, 384, 38].

Top EDAP TMS Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users